Welcome to the future of Hybrid Injectables with HArmonyCa™
HArmonyCa™ is a Hybrid Injectable that combines hyaluronic acid (HA) with calcium hydroxyapatite (CaHA), which may give your patients the benefits of immediate lift effect from HA and sustained collagen stimulation associated with CaHA, for a highly innovative way to facial harmony.*1
*Results from a pre-clinical animal study of HarmonyCaTM with results demonstrated over 8 and 12 weeks.
Adverse events should be reported.
UK: Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA
Yellow Card app, available at Google Play or Apple App stores.
Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com
Ireland: HCPs are asked to report any suspected adverse reactions via HPRA Pharmacovigilance; website: www.hpra.ie.
UK-HAR-240003 | January 2024
